Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China
· Delayed Price · Currency is CNY 10.97
+0.08 (0.73%)
Jul 11, 2025, 2:45 PM CST
SHA:603707 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 3,799 | 3,918 | 3,923 | 3,708 | 3,681 | 2,911 | Upgrade
|
Other Revenue | 5.86 | 5.86 | 8.65 | 4.61 | 5.25 | 3.55 | Upgrade
|
| 3,805 | 3,924 | 3,931 | 3,713 | 3,687 | 2,915 | Upgrade
| |
Revenue Growth (YoY) | 4.86% | -0.20% | 5.89% | 0.71% | 26.48% | 18.03% | Upgrade
|
Cost of Revenue | 2,075 | 2,112 | 3,272 | 1,778 | 1,603 | 1,236 | Upgrade
|
Gross Profit | 1,730 | 1,812 | 659.14 | 1,935 | 2,083 | 1,679 | Upgrade
|
Selling, General & Admin | 512.49 | 490.7 | 566.47 | 617.61 | 606.05 | 550.1 | Upgrade
|
Research & Development | 324.26 | 329.92 | 372.29 | 263.66 | 220.95 | 187.53 | Upgrade
|
Other Operating Expenses | 27.74 | 19.39 | 55.73 | 30.98 | 22.15 | 4.92 | Upgrade
|
Operating Expenses | 872.79 | 848.23 | 991.45 | 913 | 851.58 | 751.05 | Upgrade
|
Operating Income | 856.73 | 963.27 | -332.31 | 1,022 | 1,232 | 927.95 | Upgrade
|
Interest Expense | -69.01 | -75.66 | -81.05 | -57.85 | -92.22 | -57.57 | Upgrade
|
Interest & Investment Income | 28.71 | 21.96 | 27.98 | 60.74 | 27.53 | 11.64 | Upgrade
|
Currency Exchange Gain (Loss) | 49.79 | 49.79 | 128.88 | 154.77 | 9.37 | 1.66 | Upgrade
|
Other Non Operating Income (Expenses) | -26.91 | -6.17 | -1.35 | -0.65 | -2.74 | -7.04 | Upgrade
|
EBT Excluding Unusual Items | 839.31 | 953.19 | -257.84 | 1,179 | 1,174 | 876.65 | Upgrade
|
Gain (Loss) on Sale of Investments | -3.99 | -10.24 | -91.74 | -5.06 | 9.09 | 0.4 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.22 | -0.1 | -0.07 | -0.11 | -1.03 | -0.22 | Upgrade
|
Asset Writedown | -8.58 | -8.58 | - | - | - | - | Upgrade
|
Other Unusual Items | 57.75 | 57.76 | 54.89 | 12.02 | 21.98 | 37.8 | Upgrade
|
Pretax Income | 884.28 | 992.03 | -294.76 | 1,185 | 1,204 | 914.63 | Upgrade
|
Income Tax Expense | 150.66 | 165.93 | -105.31 | 98.85 | 139.84 | 117.98 | Upgrade
|
Earnings From Continuing Operations | 733.62 | 826.1 | -189.45 | 1,087 | 1,064 | 796.65 | Upgrade
|
Minority Interest in Earnings | 0.05 | 0.05 | 0 | 4.31 | -4.62 | 9.47 | Upgrade
|
Net Income | 733.67 | 826.14 | -189.45 | 1,091 | 1,059 | 806.12 | Upgrade
|
Net Income to Common | 733.67 | 826.14 | -189.45 | 1,091 | 1,059 | 806.12 | Upgrade
|
Net Income Growth | - | - | - | 2.98% | 31.41% | 33.25% | Upgrade
|
Shares Outstanding (Basic) | 1,641 | 1,620 | 1,579 | 1,628 | 1,581 | 1,588 | Upgrade
|
Shares Outstanding (Diluted) | 1,673 | 1,652 | 1,579 | 1,628 | 1,581 | 1,588 | Upgrade
|
Shares Change (YoY) | 5.51% | 4.66% | -3.03% | 2.98% | -0.43% | 0.94% | Upgrade
|
EPS (Basic) | 0.45 | 0.51 | -0.12 | 0.67 | 0.67 | 0.51 | Upgrade
|
EPS (Diluted) | 0.44 | 0.50 | -0.12 | 0.67 | 0.67 | 0.51 | Upgrade
|
EPS Growth | - | - | - | - | 31.97% | 32.01% | Upgrade
|
Free Cash Flow | 798.72 | 994.41 | 1,200 | 125.37 | 242.87 | -860.21 | Upgrade
|
Free Cash Flow Per Share | 0.48 | 0.60 | 0.76 | 0.08 | 0.15 | -0.54 | Upgrade
|
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.115 | 0.115 | 0.089 | Upgrade
|
Dividend Growth | - | - | -13.04% | -0.35% | 29.95% | -34.95% | Upgrade
|
Gross Margin | 45.46% | 46.17% | 16.77% | 52.11% | 56.51% | 57.60% | Upgrade
|
Operating Margin | 22.52% | 24.55% | -8.45% | 27.51% | 33.41% | 31.84% | Upgrade
|
Profit Margin | 19.28% | 21.06% | -4.82% | 29.38% | 28.73% | 27.66% | Upgrade
|
Free Cash Flow Margin | 20.99% | 25.34% | 30.53% | 3.38% | 6.59% | -29.51% | Upgrade
|
EBITDA | 1,033 | 1,135 | -178.25 | 1,161 | 1,325 | 1,013 | Upgrade
|
EBITDA Margin | 27.16% | 28.94% | -4.53% | 31.27% | 35.94% | 34.74% | Upgrade
|
D&A For EBITDA | 176.69 | 172.16 | 154.06 | 139.53 | 93.22 | 84.55 | Upgrade
|
EBIT | 856.73 | 963.27 | -332.31 | 1,022 | 1,232 | 927.95 | Upgrade
|
EBIT Margin | 22.52% | 24.55% | -8.45% | 27.51% | 33.41% | 31.84% | Upgrade
|
Effective Tax Rate | 17.04% | 16.73% | - | 8.34% | 11.62% | 12.90% | Upgrade
|
Revenue as Reported | 3,805 | 3,924 | 3,931 | 3,713 | 3,687 | 2,915 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.